These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1318951)

  • 1. Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study.
    Jeremic B; Grujicic D; Jevremovic S; Stanisavljevic B; Milojevic L; Djuric L; Mijatovic L
    J Clin Oncol; 1992 Jul; 10(7):1074-7. PubMed ID: 1318951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent malignant supratentorial astrocytomas with carboplatin and etoposide combined with recombinant mutant human tumor necrosis factor-alpha.
    Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Ikeda K; Soma G; Fukushima T
    Anticancer Res; 2002; 22(4):2447-53. PubMed ID: 12174942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study.
    Brandes AA; Ermani M; Turazzi S; Scelzi E; Berti F; Amistà P; Rotilio A; Licata C; Fiorentino MV
    J Clin Oncol; 1999 Feb; 17(2):645-50. PubMed ID: 10080610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.
    Jeremic B; Shibamoto Y; Grujicic D; Stojanovic M; Milicic B; Nikolic N; Dagovic A; Aleksandrovic J
    J Neurooncol; 2001 Jan; 51(2):133-41. PubMed ID: 11386410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study.
    Jeremic B; Shibamoto Y; Grujicic D; Milicic B; Stojanovic M; Nikolic N; Dagovic A; Aleksandrovic J
    Radiother Oncol; 1999 Apr; 51(1):27-33. PubMed ID: 10386714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study.
    Sanson M; Ameri A; Monjour A; Sahmoud T; Ronchin P; Poisson M; Delattre JY
    Eur J Cancer; 1996 Dec; 32A(13):2229-35. PubMed ID: 9038603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifosfamide, carboplatin and etoposide in recurrent malignant glioma.
    Schäfer N; Tichy J; Thanendrarajan S; Kim Y; Stuplich M; Mack F; Rieger J; Simon M; Scheffler B; Boström J; Steinbach JP; Herrlinger U; Glas M
    Oncology; 2011; 80(5-6):330-2. PubMed ID: 21791942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study.
    Robins HI; Chang SM; Prados MD; Yung WK; Hess K; Schiff D; Greenberg H; Fink K; Nicolas K; Kuhn JG; Cloughesy T; Junck L; Mehta M
    Neuro Oncol; 2002 Apr; 4(2):109-14. PubMed ID: 11916502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous carboplatin for recurrent malignant glioma: a phase II study.
    Yung WK; Mechtler L; Gleason MJ
    J Clin Oncol; 1991 May; 9(5):860-4. PubMed ID: 1849986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors.
    Castello MA; Clerico A; Deb G; Dominici C; Fidani P; Donfrancesco A
    Am J Pediatr Hematol Oncol; 1990; 12(3):297-300. PubMed ID: 2173440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51.
    Rao RD; Krishnan S; Fitch TR; Schomberg PJ; Dinapoli RP; Nordstrom K; Scheithauer B; O'Fallon JR; Maurer MJ; Buckner JC
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):380-6. PubMed ID: 15667956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study.
    Ashby LS; Shapiro WR
    J Neurooncol; 2001 Jan; 51(1):67-86. PubMed ID: 11349883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
    Wolff AC; Ettinger DS; Neuberg D; Comis RL; Ruckdeschel JC; Bonomi PD; Johnson DH
    J Clin Oncol; 1995 Jul; 13(7):1615-22. PubMed ID: 7602350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study.
    Lassen U; Kristjansen PE; Wagner A; Kosteljanetz M; Poulsen HS
    J Neurooncol; 1999 Jun; 43(2):161-6. PubMed ID: 10533728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
    Figlin RA; Crowley JJ; Jacobs EL; Muirhead M; Goodwin JW; Rinehart JJ; Livingston RB
    Cancer; 1996 Sep; 78(5):998-1003. PubMed ID: 8780537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: a phase II study.
    Ameri A; Poisson M; Chauveinc L; Chen QM; Delattre JY
    J Neurooncol; 1997 Apr; 32(2):155-60. PubMed ID: 9120545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.
    Williams PC; Henner WD; Roman-Goldstein S; Dahlborg SA; Brummett RE; Tableman M; Dana BW; Neuwelt EA
    Neurosurgery; 1995 Jul; 37(1):17-27; discussion 27-8. PubMed ID: 8587686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy protocol "8 drugs in 1 day" in patients with recurrent malignant glioma].
    Jeremić B; Grujicić D; Matović M
    Srp Arh Celok Lek; 1994; 122(3-4):73-5. PubMed ID: 17972813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.
    Faylona EA; Loehrer PJ; Ansari R; Sandler AB; Gonin R; Einhorn LH
    J Clin Oncol; 1995 May; 13(5):1209-14. PubMed ID: 7738623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.